Product Information
VIBERZI 100 MG TABLET is a brand product labeled by Allergan, Inc., priced at $28.0935 per EA under NDC 61874010060. Its NADAC has been published 555 times since Feb 17, 2016.
FDA first approved this application on May 27, 2015.
Strength
100 mg/1
Manufacturer
Allergan, Inc.NDC
61874010060
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ELUXADOLINEApproval Type
New Drug (NDA)
FDA Application
NDA206940FDA Approved
5/27/2015
On Market Since
10/1/2015
Pharmacological Classes
Price Statistics
The NADAC for VIBERZI 100 MG TABLET has been published 555 times since Feb 17, 2016, and over the history we have for it it has risen 81.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $28.0935 per EA |
|---|---|
| All-time high | $28.1349 (May 13, 2026) |
| All-time low | $15.4724 (Nov 23, 2016) |
| 52-week high | $28.1349 |
| 52-week low | $26.7932 |
| Median price | $22.0992 |
| Average price | $21.9097 |
| Largest weekly change | +9.5% (Jan 10, 2018) |
| Weeks tracked | 555 |
| Tracking since | Feb 17, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Eluxadoline market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Eluxadoline market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VIBERZI 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VIBERZI 100 MG TABLET, manufactured by Allergan, Inc., is $28.0935 per EA (NDC 61874010060), effective Sep 30, 2026.
How has the price of VIBERZI 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for VIBERZI 100 MG TABLET has risen 81.1%. It has been tracked across 555 weekly CMS publications since Feb 17, 2016.
What are the highest and lowest recorded NADAC prices for VIBERZI 100 MG TABLET?
Since Feb 17, 2016, the NADAC for VIBERZI 100 MG TABLET has ranged from a low of $15.4724 (Nov 23, 2016) to a high of $28.1349 (May 13, 2026), with a median of $22.0992 per EA.
Are there cheaper alternatives to VIBERZI 100 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of VIBERZI 100 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VIBERZI 100 MG TABLET?
VIBERZI 100 MG TABLET (NDC 61874010060) is labeled by Allergan, Inc., and CMS classifies it as a brand product.